501 filings
Page 5 of 26
8-K
mdse6d6 r7pv
8 Feb 19
Other Events
5:34pm
DEFA14A
8ai3x4
8 Feb 19
Additional proxy soliciting materials
5:30pm
PX14A6G
7q1r1e glpz5m8x
8 Feb 19
Letter to shareholders
12:17pm
8-K
59hc8eahjcj 0b4x
29 Jan 19
Allergan Reports Fourth Quarter and Full-Year 2018 Financial Results
7:15am
8-K
j5jjmz4t7vmhdl08
25 Jan 19
Other Events
5:07pm
8-K
ll3gko x1brgl
15 Nov 18
Entry into a Material Definitive Agreement
4:31pm
8-K
2ks 8p9t1ow3l2i3
13 Nov 18
Entry into a Material Definitive Agreement
5:03pm
424B2
ukh1b
9 Nov 18
Prospectus for primary offering
5:24pm
424B5
43w7r70b rhan6j7mf5
8 Nov 18
Prospectus supplement for primary offering
6:08am
8-K
rf9 binig1
1 Nov 18
Regulation FD Disclosure
12:00am
8-K
594boy
30 Oct 18
Allergan Reports Third Quarter 2018 Results Including GAAP Net Revenues of $3.9 Billion
6:45am
8-K
99carwb2t2orl9o
29 Aug 18
Departure of Directors or Certain Officers
12:00am
8-K
ue7n522k
8 Aug 18
Departure of Directors or Certain Officers
4:16pm
8-K
jfimvca971i5
26 Jul 18
Allergan Reports Strong Second Quarter 2018 Results Including GAAP Net Revenues of $4.1 Billion
6:45am
8-K
atg4jatc6nu e1
14 Jun 18
Departure of Directors or Certain Officers
12:00am
SD
sbvj2 wep8mudt1zyw
31 May 18
Conflict minerals disclosure
4:16pm